Company: NCEL
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026428
Chunk: 213

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: F-4/A
Chunk 213
---
 consideration in negotiation included deal structure, valuation methodologies, closing conditions and timelines, legal risks such as pending litigation or disputes, employee -relatedissues encompassing contracts and benefits, and intellectual property and licensing considerations. The latter entailed ownership and transfer of patents, trademarks, and proprietary technology, as well as ongoing licensing agreements, third -partydependencies, and their implications for research, development, and innovation strategies moving forward. Further topics encompassed shareholder approvals, human resource allocations — notably the leadership of the DOXA program — integration plans, post -Mergerstrategies, and decisions regarding branding and corporate identity, including the selection of a new name for the combined entity. In the course of these negotiations, Kadimastem specifically requested that Alexander Zwyer remain on the board of directors for a period of one year following the date of Closing, underscoring their interest in maintaining continuity and expertise during the transitional phase. On August 25, 2024, Sullivan sent a revised draft of the Merger Agreement to Pearl Cohen, which included comments regarding the representations and warranties, post -closingboard of directors, and the proposed exchange ratio. The parties initially agreed to confirm the representations and warranties for both parties. On August25, 2024, Mr.Zwyer and Mr.Twito had a call to discuss the potential role and engagement of Eric Konofal in the combined company after the Merger. On August29, 2024, NLS and Kadimastem met with Donohoe Advisory Associates LLC, or the Donohoe Advisors, to discuss the financial projections of the combined company. Donohoe guided NLS and Kadimastem through Nasdaq compliance and the Merger process by leveraging their expertise in U.S. stock exchange listing requirements, as demonstrated by their assistance in assessing and resolving NLS’s prior stockholders’ equity deficiencies to secure Nasdaq approval, while also providing input in structuring the Merger to meet Nasdaq’s initial and continued listing standards and post -Mergergovernance to ensure the combined company could trade on the Nasdaq Capital Market. Between August 25, 2024 and September 13, 2024, Sullivan and Pearl Cohen exchanged drafts and negotiated further the aforementioned terms of the Merger Agreement. 97 On August 29, 2024, Pearl Cohen sent the initial draft of the CVR Agreement to Sullivan. Between August 29, 2024 and November 4, 2024, Sullivan and Pearl Cohen exchanged drafts and negotiated the terms of